Fact CheckerSign in

NCT06059027Completed

Microbes and Respiratory Illnesses

Microbes and Respiratory Illnesses, The MARI Study

Source: ClinicalTrials.gov · Last updated 16 Jan 2026

Brief summary (registry, in English)

This study is called the Microbes and Respiratory Illnesses (MARI) Study. Children growing up on farms are exposed to many types of microbes that could be beneficial. It is thought that increased exposure to certain types of microbes early in life helps to develop a healthy immune system and reduce the risk for severe common cold illnesses, breathing problems, and allergies.

Status (registry)
Completed
Study type
Observational
Enrollment
290 (actual)
First submitted
22 Sept 2023
Start date
18 Oct 2023
Primary completion date
6 Nov 2025
Lead sponsor
University of Wisconsin, Madison
Diseases
Asthma
NCT number
NCT06059027

What you commit to

  • Study type: Observational
  • Participants enrolled: 290
  • From 18 Oct 2023 to the primary completion date, 6 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Chronic sinusitis (frequent sinus infections)

Lab values

  • Past or current medical problems or findings from physical examination or laboratory testing that are not listed above, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study

Other

  • Inability or unwillingness of a participant to give written informed consent or comply with study protocol
  • Plans to move out of the area before completing the study
  • Enrolled family member

Who the study is looking for

  • Participant and/or parent guardian must be able to understand and provide informed consent
  • Children ages 4-12 years of age
  • Cohort 1: Family is self-identified as Traditional agrarian (TA) Community member
  • Cohort 2: Madison-area children with parental report of doctor-diagnosed asthma
  • Cohort 3: Madison-area children with no history of asthma by parental report
  • Cohort 4: Madison-area children who have an active respiratory illness

Age in the registry: 4 years to 12 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Wisconsin School of Medicine and Public Health
Coordinator of this site? Confirm its status
MadisonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.